Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00005095 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary completion date: Dec 2020 to Dec 2030Primary endpoint revised · Completion date: Dec 2040 · Interventions: laboratory biomarker analysis (Other), screening questionnaire administration (Other), study of high risk factors (Procedure) to Ca-125 (Other), Surgery (Procedure), screening questionnaire administration (Other) · 2 morev38Show 5 more changesShow less
Primary endpoint revised
Completion date: Dec 2040
Interventions: laboratory biomarker analysis (Other), screening questionnaire administration (Other), study of high risk factors (Procedure) to Ca-125 (Other), Surgery (Procedure), screening questionnaire administration (Other)
Minor6 versionsRe-verified since May 14, 2013, no change to tracked fieldsv32-v37
MinorEligibility criteria expanded, about 36 wordsStudy description expanded, about 9 words · Study title expanded, about 5 wordsv31Show 2 more changesShow less
NotablePhase: Not applicable to Not specifiedLead sponsor: Robert H. Lurie Cancer Center to Northwestern University · Primary endpoints: 3 to 1 · Primary completion date: Dec 2020 · 4 morev30Show 7 more changesShow less
Lead sponsor: Robert H. Lurie Cancer Center to Northwestern University
Primary endpoints: 3 to 1
Primary completion date: Dec 2020
Interventions: evaluation of cancer risk factors (Procedure), laboratory biomarker analysis (Other), screening questionnaire administration (Other), study… to laboratory biomarker analysis (Other), screening questionnaire administration (Other), study of high risk factors (Procedure)
MinorInterventions: chromosomal translocation analysis (Genetic), comparative genomic hybridization (Genetic), cytology specimen collection procedure (Other)… to evaluation of cancer risk factors (Procedure), laboratory biomarker analysis (Other), screening questionnaire administration (Other), study…Eligibility criteria expanded, about 23 words · Study description shortened, about 142 words · Study title shortened, about 1 wordv29Show 3 more changesShow less
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: To improve strategies for detection and prevention of early-stage disease.
PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.